pre-update Archives

On-Demand Webinar

Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection

For the past two years, the biotech sector saw a surge of venture funding and…

CertaraAugust 30, 2022

Blog

3 Major Implications of New European Clinical Trial Regulations

Have you heard the buzz around the new European Union Clinical Trial Regulations (EU-CTR) for…

CertaraAugust 25, 2022

Blog

Mind-blowing applications of QSP in drug development: Part 2

Part 2 of this blog series dives further into the June 2022 podcast with R&D…

CertaraAugust 15, 2022

Blog

Why are Human Radiolabeled Mass-balance Studies Important in Clinical Pharmacology & Drug Development?

Human mass-balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies.”…

CertaraAugust 5, 2022

Blog

Mind-blowing applications of QSP in drug development: Part 1

R&D World editors, Paul Heney and Aimee Kalnoskas, have their minds blown — multiple times!…

CertaraAugust 4, 2022

Blog

How Pharmaceutical Companies Can Engage Payers Digitally

Pharmaceutical companies should seize opportunities to digitally engage with payers globally using both face-to-face and…

CertaraJuly 29, 2022

Blog

How the Simcyp Discovery Simulator will Accelerate Early Drug Development

Physiologically-based pharmacokinetic (PBPK) modeling is a technique used to predict the absorption, distribution, metabolism, and…

CertaraJuly 19, 2022

Video

Certara DIA Software Promo

CertaraJuly 18, 2022

Brochure

Simcyp® Discovery Simulator

Tailored for discovery and translational scientists, Simcyp® Discovery Simulator is an intuitive software that delivers…

CertaraJuly 14, 2022

Press Release

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

PRINCETON, N.J.— July 12, 2022-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

CertaraJuly 12, 2022

pre-update

Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection

3 Major Implications of New European Clinical Trial Regulations

Mind-blowing applications of QSP in drug development: Part 2

Why are Human Radiolabeled Mass-balance Studies Important in Clinical Pharmacology & Drug Development?

Mind-blowing applications of QSP in drug development: Part 1

How Pharmaceutical Companies Can Engage Payers Digitally

How the Simcyp Discovery Simulator will Accelerate Early Drug Development

Certara DIA Software Promo

Simcyp® Discovery Simulator

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

Newsletter sign up

Quick links

Solutions

Contact